PTVE News and Press, Pactiv Evergreen Inc. From 05/03/24

2024-05-03 13:09:52 ET More on Pactiv Evergreen Pactiv Evergreen: Attractive FCF Yield Profile Once Cost Savings Program Ends Pactiv Evergreen Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on Pactiv Evergreen Read the full article on Seeking ...

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 11.6% to $0.3271 on volume of 42,007,446 shares Vaxxinity Inc. (VAXX) rose 30.5% to $0.136 on volume of 33,389,450 shares Apple Inc. (AAPL) rose 6.3% to $184.01 on volume of 31,437,720 shares PROSHARES...

2024-05-02 16:20:20 ET More on Pactiv Evergreen Pactiv Evergreen: Attractive FCF Yield Profile Once Cost Savings Program Ends Pactiv Evergreen Inc. (PTVE) Q4 2023 Earnings Call Transcript Pactiv Evergreen Inc. 2023 Q4 - Results - Earnings Call Presentation Pa...

2024-05-01 17:35:49 ET More on Pactiv Evergreen Pactiv Evergreen: Attractive FCF Yield Profile Once Cost Savings Program Ends Pactiv Evergreen Inc. (PTVE) Q4 2023 Earnings Call Transcript Pactiv Evergreen Inc. 2023 Q4 - Results - Earnings Call Presentation Se...

LAKE FOREST, Ill., April 18, 2024 (GLOBE NEWSWIRE) -- Pactiv Evergreen (NASDAQ: PTVE) today announced the following details for its first quarter 2024 earnings release and teleconference call. Participants may access the live webcast on the Company’s Investor Relations website at ...

2024-04-14 02:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-04 04:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-21 09:58:26 ET Summary I upgrade my rating for Pactiv Evergreen stock from neutral to buy due to early signs of demand recovery and successful cost reduction efforts. PTVE's 4Q23 revenue fell, but EBITDA improved, indicating margin expansion. The stock price dropped due to...

2024-03-15 01:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-04 14:30:02 ET RBC Capital analyst issues UNDERPERFORM recommendation for PTVE on March 4, 2024 02:00PM ET. The previous analyst recommendation was Underperform. PTVE was trading at $13.015 at issue of the analyst recommendation. The overall analyst consensus : B...